Effects of Immunosuppressive Medications on Mitochondrial Function.

Area of Science:

• Immunology
• Cell Biology
• Pharmacology

Background:

• Immunosuppressive medications are crucial for preventing transplant rejection and graft-versus-host disease.
• Off-target effects of these drugs, potentially involving mitochondria, can impact their clinical utility.

Purpose of the Study:

• To investigate the impact of common immunosuppressive drugs on human T-cell mitochondrial function.
• To assess effects on mitochondrial membrane potential, ROS production, and apoptosis.

Main Methods:

• Human T-cells were treated with therapeutic doses of mycophenolate mofetil (MMF), cyclosporine A (CsA), rapamycin, and tacrolimus.
• Mitochondrial function assays included membrane potential, ROS production, cytochrome c release, and oxygen consumption.
• Flow cytometry and Western blot were used to quantify cellular changes.

Main Results:

• Mycophenolate mofetil (MMF) significantly induced T-cell mitochondrial depolarization, ROS production, and apoptosis.
• MMF treatment decreased T-cell basal oxygen consumption, indicating impaired energy production.
• CsA showed a trend towards decreased oxygen consumption, while rapamycin and tacrolimus had minimal effects on mitochondrial function.

Conclusions:

• Impairment of T-cell mitochondrial function by immunosuppressants like MMF can affect T-cell differentiation and function.
• Decreased energy production, increased ROS, and apoptosis are key mechanisms of MMF-induced T-cell dysfunction.
• These findings highlight the mitochondrial toxicity of certain immunosuppressive agents, relevant for optimizing transplant therapies.